AbCellera Biologics Inc. ABCL Income Tax Reconciliation Change In Tax Rate Differential
Income Tax Reconciliation Change In Tax Rate Differential at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:IncomeTaxReconciliationChangeInTaxRateDifferential.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s income tax reconciliation change in tax rate differential.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s income tax reconciliation change in tax rate differential?
- AbCellera Biologics Inc. (ABCL) reported income tax reconciliation change in tax rate differential of -$269.25K in Q4 2024.
- How has AbCellera Biologics Inc.'s income tax reconciliation change in tax rate differential changed year-over-year?
- AbCellera Biologics Inc.'s income tax reconciliation change in tax rate differential decreased by 203.4% year-over-year, from $260.5K to -$269.25K.
- What does income tax reconciliation change in tax rate differential mean?
- This captures the impact of changes in statutory tax rates across different jurisdictions where the company operates. It reflects how shifts in local or international tax legislation affect the company's deferred tax assets and liabilities. Investors monitor this to evaluate the sensitivity of the company's tax profile to global regulatory changes.